INS and metabolic disease: And systemic metabolic disorders of glucose and lipid were also amplified by the miR-665-3p agomir upon HFD stimulation, as evidenced by the increased levels of FBG, serum insulin, HOMA-IR, serum TG and TC (Figure S2D-G).